Search results
Agios (AGIO) Up 21% on Upbeat Data From 2nd Thalassemia Study
Zacks via Yahoo Finance· 5 days agoData from a late-stage study shows that transfusion-dependent thalassemia patients who received...
Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought
Motley Fool via Yahoo Finance· 12 hours agoThe stock has lost 47% over the past three years, but now may be the perfect time to get in on this...
Will FLiRT COVID variants bring another summer surge? What to know about symptoms and potential for...
Fortune via Yahoo Finance· 4 days ago...Disabilities Heart conditions HIV Immunocompromised condition or weakened immune system Mental...
Gene therapy and employee benefits: from science fiction to medical reality
BenefitsPRO· 6 days agoAs of late May 2024, 14 gene therapies are FDA-approved for a range of conditions including sickle...
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June...
Benzinga· 4 hours agoMid-cap stocks saw significant gains last week, with top performers like AGIO, VRNT, and NVAX,...
Agios Pharmaceuticals' blood disorder drug succeeds in late-stage study
Reuters· 6 days ago, opens new tab said on Monday its experimental treatment for an inherited blood disorder met the main goal in a late-stage study. The drug candidate, mitapivat, significantly reduced the need ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 6 days ago– Study Achieved the Primary Endpoint; Mitapivat Demonstrated a Statistically Significant Transfusion Reduction Response Compared to Placebo – – Statistical Significance Achieved for All Key Secondary Endpoints Evaluating Additional Measures
Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You?
Motley Fool via Yahoo Finance· 5 days agoCasgevy treats or functionally cures a pair of inherited blood diseases, sickle cell disease (SCD)...
Is Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) the Leading Gene Therapy Stock to Buy Now?
Insider Monkey via Yahoo Finance· 6 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
Why Is Agios Pharmaceuticals Stock Trading Higher On Monday? - Agios Pharmaceuticals (NASDAQ:AGIO)
Benzinga· 6 days agoShares Agios Pharmaceuticals Inc.’s AGIO climbed after it was revealed a Phase 3 ENERGIZE-T study of...